D C Yu

674 citations
6 papers · 558 · h-index 4

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 1
    • Virus-based gene therapy research 2

D C Yu

4 papers receiving 533 citations

Peers

D C Yu
Comparison fields: 5 of 49
  • Gastroenterology 158
  • Genetics 315
  • Oncology 171
  • Biotechnology 58
  • Pharmacy 17
Replace Juerong Feng with:
Juerong Feng China
Z J Zhang China
Nicholas Rogers United States
Valérie Sales Canada
Markus A. Hölzl Austria
A. J. Bone United Kingdom
Abhirami A. Ananth Canada
Miki Yamano Japan
Chin Voon Tong Malaysia
Helen Cox United Kingdom
D C Yu relative to Juerong Feng China Juerong Feng's profile →
Citations per field
00.5×5×11.6×
Juerong Feng · 1×
Citations per year

Countries citing papers authored by D C Yu

Since Specialization
Citations

This map shows the geographic impact of D C Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D C Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D C Yu more than expected).

Fields of papers citing papers by D C Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D C Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D C Yu. The network helps show where D C Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside D C Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D C Yu Line = papers co-authored together D C Yu links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 2010218
2
The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts.
1999199
3
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
2001138
4 20063
5 20250
6 20250

About D C Yu

D C Yu is a scholar working on Oncology, Genetics, Biotechnology, Surgery and Molecular Biology, having authored 6 papers that have together received 558 indexed citations. Recurring topics across this work include Virus-based gene therapy research (2 papers), Cancer Research and Treatments (2 papers), Endometrial and Cervical Cancer Treatments (1 paper), Bladder and Urothelial Cancer Treatments (1 paper), Urinary and Genital Oncology Studies (1 paper), Prostate Cancer Treatment and Research (1 paper), Head and Neck Cancer Studies (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Gastroenterology (158 citations), Genetics (315 citations), Oncology (171 citations), Biotechnology (58 citations) and Pharmacy (17 citations). D C Yu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jeanette Dilley, Daniel Henderson, Yu Chen, Michaela Su-Fern Seng, David Karpf, Yu Chen, Theodore L. DeWeese, Naveen Ramesh, Simon D. Scott and Jennifer Stephens. Their work appears in journals such as Gut, Oncology Reports, The Journal of Urology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact